There were 523 press releases posted in the last 24 hours and 431,882 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image